Evidence map›Paper›PMID 19648268›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2009

C3 promotes expansion of CD8+ and CD4+ T cells in a Listeria monocytogenes infection.

Yumi Nakayama, Shin-Il Kim, Eui Ho Kim, John D Lambris, Matyas Sandor, M Suresh

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. An Immunomodulatory Transcriptional Signature Associated With PersistentFrontiers in cellular and infection microbiology · 2021
    Article
  6. Complement andFrontiers in immunology · 2021
    Article
  7. Complement andFrontiers in immunology · 2021
    Article
  8. Innate and Adaptive Immune Responses duringMicrobiology spectrum · 2019
    Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Complement activation is not required for obliterative airway disease induced by antibodies to major histocompatibility complex class I: Implications for chronic lung rejection.The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2012
    Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yumi NakayamaDepartment of Pathobiological Sciences, University of Wisconsin, Madison, WI 53706, USA.
Shin-Il Kim
Eui Ho Kim
John D Lambris
Matyas Sandor
M Suresh
University of Wisconsin–Madison · USUniversity of Pennsylvania · US

Funding

Role of complement in kidney disorders: from hemodialysis to transportationP01AI068730 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI LAMBRIS, JOHN D · 2007 to 2018
$16.0M
Regulation of CD8 T Cell Immunity by TNF ReceptorsR01AI048785 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI SURESH, MARULASIDDAPPA · 2002 to 2012
$3.3M
STRUCTURAL-FUNCTIONAL ANALYSIS OF COMPSTATINR01GM062134 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI LAMBRIS, JOHN D · 2001 to 2010
$2.5M
Direct Regulation of CD8 T Cells by Interferon gammaR01AI059804 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI SURESH, MARULASIDDAPPA · 2004 to 2010
$1.4M
Enhancement of CD8 T Cell Immunity by IL-7 TherapyR21AI068841 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI SURESH, MARULASIDDAPPA · 2007 to 2008
$393k
REGULATION OF CD8 T CELL IMMUNITY BY TNF RECEPTORSR21AI048785 · NIAID · UNIVERSITY OF WISCONSIN MADISON · PI SURESH, MARULASIDDAPPA · 2001 to 2001
$291k
NIAID NIH HHS AI068841NIAID NIH HHS AI48785NIAID NIH HHS AI59804NIAID NIH HHS AI68730NIAID NIH HHS P01 AI068730NIAID NIH HHS R01 AI048785NIAID NIH HHS R01 AI059804NIAID NIH HHS R21 AI048785NIAID NIH HHS R21 AI068841NIGMS NIH HHS GM062134NIGMS NIH HHS R01 GM062134
6 · The paper itself

Abstract

It is known that C3 is required for optimal expansion of T cells during acute viral infections. However, it is not yet determined whether T cell responses to intracellular bacterial infections require C3. Therefore, we have investigated the requirement for C3 to elicit potent T cell responses to Listeria monocytogenes (LM). We show that expansion of Ag-specific CD8 and CD4 T cells during a primary response to LM was markedly reduced in the absence of C3 activity. Further studies indicated that, unlike in an influenza virus infection, the regulation of LM-specific T cell responses by C3 might not involve the downstream effector C5a. Moreover, reduced T cell responses to LM was not linked to defective maturation of dendritic cells or developmental anomalies in the peripheral T cell compartment of C3-deficient mice. Experiments involving adoptive transfer of C3-deficient CD8 T cells into the C3-sufficient environment of wild-type mice showed that these T cells do not have intrinsic proliferative defects, and a paracrine source of C3 will suffice for clonal expansion of CD8 T cells in vivo. However, stimulation of purified C3-deficient CD8 T cells by plastic-immobilized anti-CD3 showed that C3 promotes T cell proliferation directly, independent of its effects on APC. On the basis of these findings, we propose that diminished T cell responses to LM in C3-deficient mice might be at least in part due to lack of direct effects of C3 on T cells. These studies have furthered our understanding of C3-mediated regulation of T cell immunity to intracellular pathogens.

Indexed as

Cell ProliferationAnimalsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesComplement C3Listeria monocytogenesListeriosisLymphocyte ActivationMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicReceptor, Anaphylatoxin C5aComplement C3Receptor, Anaphylatoxin C5a

Identifiers

PMID19648268
PMCPMC2753887
OpenAlexW1905089855

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.